Intelligence Platform
Patents
Browse 2,828 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 9399627
Substituted macrocyclic compounds having proteasome inhibitory activity
granted patentUS 9394316
Inhibitors of the plasmodial surface anion channel as antimalarials
granted patentUS 9394303
Small molecule inhibitors of MCL-1 and uses thereof
granted patentUS 9394302
Inhibitors of influenza viruses replication
granted patentUS 9393245
Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors
granted patentUS 9388408
Oligonucleotide-based inhibitors comprising locked nucleic acid motif
granted patentUS 9388189
Pyrrolotriazinone derivatives as PI3K inhibitors
granted patentUS 9388145
Neprilysin inhibitors
granted patentUS 9387205
Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors
granted patentUS 9382256
Formulation of Syk inhibitors
granted patentUS 9382213
Heterocyclic and cyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase
granted patentUS 9376448
DNA-PK inhibitors
granted patentUS 9375438
Inhibitors of NCCa-ATP channels for therapy
granted patentUS 9375402
Oral formulations of kinase inhibitors
granted patentUS 9371337
Ξ²-lactamase inhibitors
granted patentUS 9370519
Macrocyclic FLT3 kinase inhibitors
granted patentUS 9370505
Pharmaceutical compositions comprising an aromatse inhibitors
granted patentUS 9365612
Caspase inhibitors
granted patentUS 9365602
Sodium glucose co-transporter inhibitors and methods of their use
granted patentUS 9365557
Substituted pyrazin-2-amines as inhibitors of ATR kinase
granted patentUS 9365549
Hepatitis C virus inhibitors
granted patentUS 9359418
Inhibitors of the T cell-specific alternative p38 activation pathway and methods of use
granted patentUS 9359380
DNA-PK inhibitors
granted patentUS 9359309
Synthesis of syrbactin proteasome inhibitors
granted